HCPLive Network
Latest Specialty Pharmacy Headlines
By Davy James, Associate Editor
Experimental drug results in 100% recovery in primates up to 5 days following infection.
By Davy James, Associate Editor
A protein found in nearly half of African Americans speeds removal of medication from the body.
By Davy James, Associate Editor
Phase I study deems treatment safe and tolerable in humans.
By Eileen Oldfield, Associate Editor
Medicaid beneficiaries are more likely to be screened for 3 types of cancer in states where physicians receive higher payments for office visits, a study suggests.
By Davy James, Associate Editor
Treatment co-developed by National Institutes of Health and GlaxoSmithKline gets fast-tracked as World Health Organization issues dire prediction.
By Davy James, Associate Editor
Limitations in available staff and protective equipment put medical personnel at increased risk.
By Davy James, Associate Editor
First-in-class treatment option available for severe aplastic anemia patients who had insufficient responses to immunosuppressive therapy.
By Davy James, Associate Editor
Efficacy of treatment still undetermined as World Health Organization raises cost of battle strategy.
By Eileen Oldfield, Associate Editor
Examining infliximab dose escalation rates could help maximize cost-benefit treatment algorithms.
By Davy James, Associate Editor
A different Ebola strain reported in Congo as researchers race to find a vaccine.
Physician's Money Digest
Healthcare practices continue to suffer from embezzlement problems. While there is no such thing as a perfect system to prevent embezzlers, there are ways to deter them.
Most people don’t realize how closely emotions affect financial spending, which can lead to poor decisions and overspending. But knowing potential triggers can help you overcome them in the future.